PCR detects fungal DNA in keratitis

Article

Polymerase chain reaction (PCR) could be used to diagnose fungal keratitis.

Polymerase chain reaction (PCR) could be used to diagnose fungal keratitis, claims an investigation in the journal Eye.

A team led by Dr N. Tananuvat, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, conducted a prospective nonrandomized study on 30 eyes of 30 patients with presumed fungal keratitis.

Each patient underwent corneal scraping and fungal-specific primers were used to analyse the specimens. PCR products were cloned and sequenced and compared to conventional microbial work-up.

PCR demonstrated positivity in 93.3%, culture in 40% and potassium hydroxide in 20% of the total patients included in the study. Out of the 28 PCR-positive patients, 12 were culture-positive and 16 were culture-negative.

There were no false-negative results in the culture-positive specimens recorded by the PCR, suggesting it is able to accurately detect fungal DNA in a high percentage of culture-negative cases. The procedure could be helpful, in addition to smear and culture in the efficient diagnosis of fungal keratitis.

Please click here to read the abstract.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.